Rafferty Asset Management »

Prime Medicine shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $651k 188k 3.47
2023-09-30 $1.2M 129k 9.54

More positions owned by Rafferty Asset Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Vaneck Etf Trust Gold Miners Etf (GDX)
Applied Materials (AMAT)
Ishares Tr China Lg-cap Etf (FXI)
Lam Research Corp Com New (LRCX)
Qualcomm (QCOM)
Kla Corp Com New (KLAC)

View all positions for Rafferty Asset Management

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
ARK Investment Management
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
Geode Capital Management
UBS Group
D. E. Shaw & Co

View all funds holding Prime Medicine